These results indicate that abnormal activation of NF-κB signalling, via loss of Mecp2 modulation of Irak1 expression, is centrally involved in the pathogenesis of Mecp2-null mice and, therefore, likely RTT. Here, MECP2 is linked to Rett syndrome.